On July 17, 2020, the National Broadcasting Company and the leading U.S. news portal NBC NEWS published a report on the innovative coronavirus diagnostic device DSA-090 on its official website.
A report from a study published on bioRxiv: in Brazil, scientists have identified six major groups of SARS-CoV-2 coronavirus circulating in the world.
Biopharmaceutical company «Gilead Sciences» has released an antiviral drug for treatment of COVID-19.
Scientists from Canada conducted a detailed global study of the effectiveness of measures to prevent coronavirus infection.
Early detection of coronavirus infection in asymptomatic individuals is associated with the detection of loss of smell.
A scientist from Australia claims that Covid-19 will be a seasonal disease in periods of low humidity.
An autopsy showed that in deceased patients with COVID-19 blood clots block the blood vessels of the lungs, which leads to death.
The researchers found that the body of a smoker produces an intense protein that allows SARS-COV-2 to enter the cells.
As you know, an innovative device for digital diagnostics of CoViD-19 coronavirus infection spreading rapidly around the world arrived from Kazakhstan to Finland.
After a long lull in one of the provinces of China, several confirmed cases of COVID-19 were discovered.
Researchers from Korea, tested 48 drugs approved by the FDA against SARS-CoV-2 and found that two of them have a promising perspective in the application.
"Artificial sniffer" was created in the Finnish capital laboratory under the guidance of professor Risto Orava. It promises to be the fastest and the cheapest way to diagnose the new coronavirus in the world: the device detects the SARS-CoV-2 in 3-4 exhales, and its value is estimated at between 5 and 6 euros.